Cargando…

Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine

OBJECTIVE: Long-term HCQ use for the treatment of rheumatic diseases has been associated with retinopathy in a daily and cumulative dose-dependent manner by weight. We examined the incidence of ocular toxicity in a large population of patients treated with HCQ for inflammatory arthritis and SLE and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Dilpreet K, Muhieddine, Leila, Einstadter, Douglas, Ballou, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649895/ https://www.ncbi.nlm.nih.gov/pubmed/31431997 http://dx.doi.org/10.1093/rap/rkz009

Ejemplares similares

Comment on: incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine: reply
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021)

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series
por: Malik, Mariam, et al.
Publicado: (2023)

COVID-19-related anxiety trajectories in children, young people and adults with rheumatic diseases
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2023)

Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing
por: Li, Jia, et al.
Publicado: (2021)

Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry
por: Conway, Richard, et al.
Publicado: (2021)

Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021)

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
por: Rome, Benjamin N., et al.
Publicado: (2021)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID‐19
por: Décary, Simon, et al.
Publicado: (2020)

Self-perceived disease activity was the strongest predictor of COVID-19 pandemic-related concerns in young people with autoimmune rheumatic diseases, irrespective of their gender, with females reporting higher concerns
por: Peng, Junjie, et al.
Publicado: (2022)

Efficacy of MitoHeal (®) supplementation on adult skin quality and patient satisfaction: a randomized, double‐blind, placebo‐controlled, pilot study
por: Hooper, Stephanie, et al.
Publicado: (2022)

Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study
por: Parker, Matthew J S, et al.
Publicado: (2018)

Barriers and facilitators of adherence to the use of ASICA, a digital app designed to support people previously treated for melanoma: concise report of a qualitative study
por: Ntessalen, Maria, et al.
Publicado: (2023)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
por: Nirk, Eliise Laura, et al.
Publicado: (2020)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study
por: Petersen, Magnus B, et al.
Publicado: (2023)

A Case of Solitary Labial Porokeratosis Extending into Oral Mucosa Treated with Topical 5-Fluorouracil
por: Gongale, Sayali P., et al.
Publicado: (2021)

Evaluating the incidence of bacteriuria in female patients before and after implementation of external urinary collection devices
por: Noval, Mandee M., et al.
Publicado: (2022)

The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
por: Banks, Jamie, et al.
Publicado: (2022)

Eosinophilic Cellulitis Successfully Treated with Colchicine
por: Ozturk, Murat, et al.
Publicado: (2019)

Incidence of and Ivermectin Prescription Trends for COVID-19 in Japan
por: Watari, Takashi, et al.
Publicado: (2022)

Determining coronavirus disease 2019 (COVID-19) community incidence threshold for preoperative testing
por: Zhou, Judy, et al.
Publicado: (2022)

Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study
por: Walker, Alex, et al.
Publicado: (2020)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
por: Clark, Kristina E N, et al.
Publicado: (2020)

Superficial Variant of Pyoderma Gangrenosum Successfully Treated with Lower Dose Clofazimine
por: Mohan, Alaka J., et al.
Publicado: (2022)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
por: Macías, Juan, et al.
Publicado: (2021)

Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departments
por: Veillette, John J., et al.
Publicado: (2023)

Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic
por: Lastinger, Lindsey M., et al.
Publicado: (2022)

Successful integration of an automated patient-reported outcome measure within a hospital electronic patient record
por: Neame, Matthew T, et al.
Publicado: (2022)

ImmunoStart: preparing patients for immunosuppression
por: Martin, Charlotte, et al.
Publicado: (2021)

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus
por: Heijke, Rebecca, et al.
Publicado: (2020)

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
por: Mielnik, Pawel, et al.
Publicado: (2023)

COVID-19 Testing and Incidence Among Uninsured and Insured Individuals in 2020: a National Study
por: Gaffney, Adam, et al.
Publicado: (2022)

Feasibility study of mobile phone photography as a possible outcome measure of systemic sclerosis-related digital lesions
por: Davison, Adrian K, et al.
Publicado: (2022)

Clinical and immunological characteristics of 56 patients with systemic lupus erythematosus in Uganda
por: Bongomin, Felix, et al.
Publicado: (2020)

Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
por: Pathak, Himanshu, et al.
Publicado: (2021)

Paradoxical eczema in patients with psoriasis receiving biologics: a case series
por: Al‐Janabi, Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6kr6hugh5m5ri86ttvsmb1gt3